可注射的带有PROTAC的水凝重塑瘤微环境以加强放射性免疫疗法
Weihe Zhao1, Xiangdong Xu2, Shu An1
1Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, People's Republic of China.
概括
这项研究引入了一种可注射的水凝,可提供PROteolysis Targeting Chimeras (PROTACs) 来增强放射治疗. 这种带有PROTAC的系统可以对抗瘤免疫抑制,增强抗瘤免疫力,从而改善癌症治疗.
科学领域:
- 生物医学工程
- 癌症治疗
- 免疫学
背景情况:
- 放射治疗对癌症治疗至关重要,但可能导致免疫抑制,限制其有效性.
- 开发克服RT诱导免疫抑制的策略对于增强抗瘤功效至关重要.
研究的目的:
- 开发一种可注射的水凝系统,用于局部输送PROteolysis Targeting Chimeras (PROTACs).
- 研究RT和PROTAC对瘤生长和瘤微环境的联合作用.
- 评估该策略在逆转RT诱导的免疫抑制方面的潜力.
主要方法:
- 制造可注射水凝系统,封装携带向BRD4的PROTAC的瘤细胞膜融合的脂质体纳米粒子.
- 在瘤模型中使用水凝-PROTAC系统与RT的联合治疗.
- 对瘤细胞DNA损伤,修复,增殖和生存的评估.
- 评估免疫细胞反应,包括树突细胞成熟和T细胞透.
主要成果:
- 含有PROTAC的水凝通过促进DNA损伤和抑制瘤细胞增殖来增强RT的抗瘤作用.
- 这一策略有效地促进了树突细胞的成熟,并增加了瘤特异性的T细胞透.
- 放射治疗诱导的免疫抑制被逆转,导致增强的抗瘤免疫反应.
结论:
- 这种可注射的水凝系统为局部PROTAC输送提供了一种新方法,以提高RT的疗效.
- 这一策略成功地抵消了放射治疗引起的免疫抑制,并增强了抗瘤免疫力.
- 这项工作为PROTAC技术在癌症治疗中的临床应用提供了坚实的基础.
相关概念视频
01:27Tumor Immunotherapy
658
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
658
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K